Policy

The biomedical research system has historically been supported by two main pillars: fundamental research on the mechanisms of disease, largely funded by the National Institutes of Health (NIH), and the pharmaceutical industry, which creates products to treat these conditions. Recent advances in biomedical research and health sciences present an opportunity to change how we understand,... Read More

Published: Friday, June 24, 2022, 3:15 PM U.S. Eastern Time Media Contact: Kara Flynn, press@ashg.org Today’s U.S. Supreme Court decision overruling Roe v. Wade is unprecedented and deeply alarming. It will swiftly limit access to safe reproductive healthcare in many states and will inevitably deny pregnant people and families the choices they should have, including... Read More

Published: Wednesday, May 11, 2022, 4:00 PM U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org ROCKVILLE, MD – Today, the American Society of Human Genetics (ASHG) hosted its 2022 Capitol Hill Day bringing together 21 researchers, clinicians and other advocates from across the country to meet with key members of Congress and their staff to discuss shared... Read More

Since the pandemic began, participating in policy and advocacy as scientists has become incredibly challenging.  Interacting with both federal and local representatives has become particularly difficult, as scientists can no longer go to D.C. or to their state legislatures and meet with representatives in person.  This is frustrating, because communicating the importance of scientific research... Read More

On March 11, Congress passed a massive end-of-year spending package that included $1.5 trillion in fiscal year (FY) 2022 omnibus appropriations.  The package had broad bipartisan support, passing the House on a vote of 361-69 and the Senate on a vote of 68-31.  President Biden later signed it into law before government funding was set... Read More